Solving the Most Complex Gene Editing Problems
B-MoGen: Inventive Genome Engineering
B-MoGen Biotechnologies, Inc. focuses on complex genome engineering providing proprietary, cutting edge gene delivery and editing tools to enable faster research and cost effective therapies.
Changing the Game of Disease Treatment
At B-MoGen, we believe:
- Immunotherapy is changing the game of disease treatment
- We have the capabilities to solve the most complex gene editing problems with proprietary (licensed), new, cutting edge gene editing and delivery tools
- We are enabling and accelerating growth in immunotherapy treatments
- We are driven to engineer the best solutions
- We are a disruptor enabling life changing therapies
- We are going to make treating mitochondrial disease a reality
B-MoGen: Three Distinct Services
We utilize our unique expertise and experience to provide three distinct services that address highly complex gene delivery and gene editing.
- Fee-for-service custom cell engineering of both cell lines and, uniquely, primary human lymphohematopoietic cells for cancer research, drug screening, and antibody validation
- Non-viral transposon-based gene therapy platform to support the T Cell immunotherapy industry that drives down the cost of CAR T therapy for cancer and other diseases
- The first company in the world to demonstrate genome engineering of the mitochondria genome
B-MoGen is Different
We leverage our ingenuity and science to partner with those looking for new, novel and transformative gene editing methods to:
- lower costs
- increase potency
- provide supply chain stability
- create safer products for patients who need these life saving treatments
We enable scientists and bio-therapeutics companies to create life-changing medicines for human disease that are less expensive, more robust and more efficient.